Close X

Attorney Spotlight

How does Eli Richardson's past work with the federal government inform his client interactions? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

In June 2016, AmSurg Corp. and Envision Healthcare Holdings, Inc. (Envision) announced they have signed a definitive merger agreement pursuant to which the companies will combine in an all-stock transaction. Upon completion of the merger, which is expected to be tax-free to the shareholders of both organizations, the combined company will be named Envision Healthcare Corporation and co-headquartered in Nashville, Tennessee and Greenwood Village, Colorado. The company's common stock is expected to trade on the New York Stock Exchange under the ticker symbol: EVHC. Bass, Berry & Sims served as lead counsel on the transaction, led by Jim Jenkins. Read more.

AmSurg logo


Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Inside the FCA blogInside the FCA blog features ongoing updates related to the False Claims Act (FCA), including insight on the latest legal decisions, regulatory developments and FCA settlements. The blog provides timely updates for corporate boards, directors, compliance managers, general counsel and other parties interested in the organizational impact and legal developments stemming from issues potentially giving rise to FCA liability.

Read More >

John C. Eason

Associate

Nashville
(615) 742-7830 TEL
(615) 742-2772 FAX

John C. Eason

Associate

Nashville
(615) 742-7830 TEL
(615) 742-2772 FAX
Nashville
(615) 742-7830 TEL
(615) 742-2772 FAX

John Eason focuses his practice on representing clients in government enforcement actions, investigations, and related litigation, particularly involving the False Claims Act (FCA). John has represented companies and individuals, particularly in the healthcare industry, in responding to inquiries and investigations by the Department of Justice, U.S. Attorneys' Offices, Office of the Inspector General of the Department of Health and Human Services, and other federal and state agencies, regarding healthcare and procurement fraud issues. John also has experience defending clients against lawsuits brought under the Federal False Claims Act, state false claims acts, and other fraud statutes, as well as the FCA's anti-retaliation provision. John has assisted corporate clients with internal compliance assessments and internal investigations regarding regulatory and compliance issues. John is a contributor to and editor of the firm's annual Healthcare Fraud Year in Review and the firm's Inside the FCA Blog.

Prior to joining Bass, Berry & Sims, John served a one-year clerkship with the Honorable Anita B. Brody on the U.S. District Court for the Eastern District of Pennsylvania. John earned his law degree from Vanderbilt University Law School where he served as articles editor for the Vanderbilt Law Review and as a member of the managing council of the Moot Court Board. While in law school, he interned with the Honorable John S. Bryant, Magistrate Judge for the U.S. District Court for the Middle District of Tennessee.

Memberships

American Health Lawyers Association (AHLA)

Tennessee Bar Association

News

View More

Representative Experience

View More

Publications

View More

Media Mentions

View More

Accolades

Vanderbilt Law Review — Articles Editor

Moot Court Board — Managing Council

Law Clerk to Hon. Anita B. Brody, U.S. District Court for the Eastern District of Pennsylvania (2011-2012)

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.